ATE518009T1 - Verfahren zur diagnose und behandlung von herz- kreislauf-krankheiten - Google Patents
Verfahren zur diagnose und behandlung von herz- kreislauf-krankheitenInfo
- Publication number
- ATE518009T1 ATE518009T1 AT06829110T AT06829110T ATE518009T1 AT E518009 T1 ATE518009 T1 AT E518009T1 AT 06829110 T AT06829110 T AT 06829110T AT 06829110 T AT06829110 T AT 06829110T AT E518009 T1 ATE518009 T1 AT E518009T1
- Authority
- AT
- Austria
- Prior art keywords
- diagnosis
- treatment
- cardiovascular diseases
- cardiovascular
- diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/912—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- G01N2333/91205—Phosphotransferases in general
- G01N2333/9121—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
- G01N2333/91215—Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases with a definite EC number (2.7.1.-)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Analytical Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- General Engineering & Computer Science (AREA)
- Cell Biology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP05026569A EP1795609A1 (de) | 2005-12-06 | 2005-12-06 | Verfahren zur Diagnose und Behandlung von kardiovaskulären Krankheiten |
| PCT/EP2006/011220 WO2007065562A1 (en) | 2005-12-06 | 2006-11-23 | Method for the diagnosis and treatment of cardiovascular diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE518009T1 true ATE518009T1 (de) | 2011-08-15 |
Family
ID=35994653
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT06829110T ATE518009T1 (de) | 2005-12-06 | 2006-11-23 | Verfahren zur diagnose und behandlung von herz- kreislauf-krankheiten |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US8071297B2 (de) |
| EP (2) | EP1795609A1 (de) |
| JP (1) | JP2009518018A (de) |
| KR (1) | KR20080080527A (de) |
| CN (1) | CN101326291A (de) |
| AR (1) | AR056831A1 (de) |
| AT (1) | ATE518009T1 (de) |
| AU (1) | AU2006322316B2 (de) |
| BR (1) | BRPI0619479A2 (de) |
| CA (1) | CA2632586A1 (de) |
| IL (1) | IL191887A0 (de) |
| TW (1) | TW200741011A (de) |
| WO (1) | WO2007065562A1 (de) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5714692B2 (ja) * | 2010-03-23 | 2015-05-07 | イーエムベーアー−インスティトゥート・フューア・モレクラレ・ビオテヒノロギー・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングImba−Institut Fuermolekulare Biotechnologie Gmbh | Iii型分泌機構の阻害剤の同定方法 |
| CN104090094A (zh) * | 2013-05-28 | 2014-10-08 | 长兴化学工业股份有限公司 | 生物医学装置 |
| US20190113520A1 (en) * | 2016-03-31 | 2019-04-18 | Discerndx, Inc. | Biomarker Database Generation and Use |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5744101A (en) | 1989-06-07 | 1998-04-28 | Affymax Technologies N.V. | Photolabile nucleoside protecting groups |
| FR2739031B1 (fr) | 1995-09-27 | 1997-11-21 | Lhd Lab Hygiene Dietetique | Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base de copolymere styrene-isoprene-styrene, procede de preparation et utilisation en therapeutique |
| US5736154A (en) | 1996-03-11 | 1998-04-07 | Fuisz Technologies Ltd. | Transdermal delivery system |
| WO1997035564A1 (de) | 1996-03-25 | 1997-10-02 | Lts Lohmann Therapie-Systeme Gmbh | Transdermales therapeutisches system mit geringer applikationsdicke und hoher flexibilität sowie herstellungsverfahren |
| JP2000507544A (ja) | 1996-03-25 | 2000-06-20 | イーライ・リリー・アンド・カンパニー | 痛みの治療方法 |
| AUPO379596A0 (en) | 1996-11-22 | 1996-12-19 | Soltec Research Pty Ltd | Percutaneous delivery system |
| JP2004512014A (ja) * | 2000-05-18 | 2004-04-22 | 学校法人日本大学 | 虚血状態の検査方法 |
| US20030211525A1 (en) * | 2001-08-27 | 2003-11-13 | Walker Michael G | Genes expressed in the cell cycle |
| US20050107386A1 (en) * | 2003-11-19 | 2005-05-19 | Rama Krishna Narla | Methods of treating diseases and disorders by targeting multiple kinases |
| EP2186913B1 (de) * | 2003-11-26 | 2016-02-10 | Celera Corporation | Mit kardiovaskulären Erkrankungen und dem Ansprechen auf Medikation in Zusammenhang stehende Genpolymorphismen, Methoden zu deren Nachweis und deren Verwendung |
-
2005
- 2005-12-06 EP EP05026569A patent/EP1795609A1/de not_active Withdrawn
-
2006
- 2006-11-23 AU AU2006322316A patent/AU2006322316B2/en not_active Withdrawn - After Issue
- 2006-11-23 BR BRPI0619479-6A patent/BRPI0619479A2/pt not_active Application Discontinuation
- 2006-11-23 US US12/095,783 patent/US8071297B2/en not_active Expired - Fee Related
- 2006-11-23 CN CNA2006800458776A patent/CN101326291A/zh active Pending
- 2006-11-23 WO PCT/EP2006/011220 patent/WO2007065562A1/en not_active Ceased
- 2006-11-23 JP JP2008543688A patent/JP2009518018A/ja not_active Abandoned
- 2006-11-23 AT AT06829110T patent/ATE518009T1/de not_active IP Right Cessation
- 2006-11-23 KR KR1020087013758A patent/KR20080080527A/ko not_active Withdrawn
- 2006-11-23 CA CA002632586A patent/CA2632586A1/en not_active Withdrawn
- 2006-11-23 EP EP06829110A patent/EP1960543B1/de not_active Not-in-force
- 2006-12-04 TW TW095144873A patent/TW200741011A/zh unknown
- 2006-12-04 AR ARP060105342A patent/AR056831A1/es unknown
-
2008
- 2008-06-02 IL IL191887A patent/IL191887A0/en unknown
-
2011
- 2011-11-17 US US13/298,590 patent/US20120065078A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2007065562A1 (en) | 2007-06-14 |
| AU2006322316A1 (en) | 2007-06-14 |
| JP2009518018A (ja) | 2009-05-07 |
| EP1795609A1 (de) | 2007-06-13 |
| TW200741011A (en) | 2007-11-01 |
| AU2006322316B2 (en) | 2011-11-03 |
| KR20080080527A (ko) | 2008-09-04 |
| AR056831A1 (es) | 2007-10-24 |
| US8071297B2 (en) | 2011-12-06 |
| US20090239218A1 (en) | 2009-09-24 |
| EP1960543B1 (de) | 2011-07-27 |
| CN101326291A (zh) | 2008-12-17 |
| EP1960543A1 (de) | 2008-08-27 |
| US20120065078A1 (en) | 2012-03-15 |
| CA2632586A1 (en) | 2007-06-14 |
| BRPI0619479A2 (pt) | 2011-10-04 |
| IL191887A0 (en) | 2008-12-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602006018583D1 (de) | Verfahren und zusammensetzung zur behandlung von peripheren gefässkrankheiten | |
| EP1991274A4 (de) | Verfahren zur behandlung, prophylaxe und diagnose von knochenerkrankungen | |
| EP1896083A4 (de) | Verfahren zur behandlung von pompe-krankheit mit 1-desoxynojirimycin und derivaten | |
| EP2029743A4 (de) | Verfahren zur diagnose und behandlung von schwangerschaftskomplikationen | |
| EP1945754A4 (de) | Zusammensetzungen und verfahren zur behandlung und diagnostizierung von krebs | |
| DE602006019753D1 (de) | Verfahren und gerät zur behandlung von aneurysmen der a. thoracica | |
| EP2041317A4 (de) | Mikro-rna-basierte verfahren und zusammensetzungen zur diagnose und behandlung von erkrankungen in zusammenhang mit darmkrebs | |
| EP1916964A4 (de) | Implantate und verfahren zur behebung, ersetzung und behandlung von gelenkkrankheiten | |
| ATE550338T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
| EP2141989A4 (de) | Zusammensetzungen und verfahren zur vorbeugung und behandlung von suchtkrankheiten | |
| ATE434620T1 (de) | Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen | |
| EP1701664A4 (de) | System und verfahren zur behandlung von gewebe | |
| EP2054047A4 (de) | Verfahren zur behandlung von akutem akustischem trauma | |
| EP1799705A4 (de) | Antigenkomplex zur diagnose und behandlung von porphyromonas-gingivalis-infektion | |
| DE602006006354D1 (de) | Pinolensäure zur Behandlung von Übergewicht | |
| EP3769718C0 (de) | Vorrichtung zur behandlung von darmerkrankungen | |
| EP1550462A4 (de) | MITTEL ZUR BEHANDLUNG ODER PRûVENTION VON NIERENERKRANKUNGEN UND VERFAHREN ZUR DIAGNOSE VON NIERENERKRANKUNGEN | |
| EP1869212A4 (de) | Verwendung von id4 zur diagnose und behandlung von krebs | |
| EP2099446A4 (de) | Verfahren zur behandlung von entzündlicher darmerkrankung | |
| EP1812588A4 (de) | Anomalitäten von phosphatase 2a (pp2a) zur diagnose und behandlung von morbus alzheimer | |
| EP1709421A4 (de) | Verfahren zur diagnose und prognose von krebserkrankungen epithelialer genese | |
| EP1651237A4 (de) | Verfahren zur behandlung von dermatologischen erkrankungen | |
| DE60333195D1 (de) | Verfahren zur diagnose des myokardinfarktrisikos | |
| EP1791423A4 (de) | Zusammensetzungen und verfahren für die behandlung von hyperproliferativen hautkrankheiten | |
| EP1919290A4 (de) | Verfahren und produkte zur behandlung von krankheiten |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |